262 related articles for article (PubMed ID: 15286396)
1. Animal models of scleroderma.
Lakos G; Takagawa S; Varga J
Methods Mol Med; 2004; 102():377-93. PubMed ID: 15286396
[TBL] [Abstract][Full Text] [Related]
2. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
3. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
McCormick LL; Zhang Y; Tootell E; Gilliam AC
J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
[TBL] [Abstract][Full Text] [Related]
5. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
Choi KL; Claman HN
Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
[No Abstract] [Full Text] [Related]
6. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y
Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
9. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
Bos GM; Majoor GD; Slaaf DW; van de Gaar MJ; Weijmer-van Velzen JS; van Breda Vriesman PJ
Transplant Proc; 1989 Apr; 21(2):3262-3. PubMed ID: 2652812
[No Abstract] [Full Text] [Related]
10. SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.
Kimura M; Kawahito Y; Hamaguchi M; Nakamura T; Okamoto M; Matsumoto Y; Endo H; Yamamoto A; Ishino H; Wada M; Omoto A; Tsubouchi Y; Kohno M; Yoshikawa T
Biomed Pharmacother; 2007 May; 61(4):222-8. PubMed ID: 17147981
[TBL] [Abstract][Full Text] [Related]
11. Animal models of scleroderma: fresh insights.
Artlett CM
Curr Opin Rheumatol; 2010 Nov; 22(6):677-82. PubMed ID: 20720495
[TBL] [Abstract][Full Text] [Related]
12. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
[TBL] [Abstract][Full Text] [Related]
13. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride.
Christner PJ; Artlett CM; Conway RF; Jiménez SA
Arthritis Rheum; 2000 Nov; 43(11):2598-605. PubMed ID: 11083286
[TBL] [Abstract][Full Text] [Related]
14. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
Yamamoto T
Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.
Avouac J; Fürnrohr BG; Tomcik M; Palumbo K; Zerr P; Horn A; Dees C; Akhmetshina A; Beyer C; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2011 Mar; 63(3):800-9. PubMed ID: 21360510
[TBL] [Abstract][Full Text] [Related]
16. Murine models of graft-versus-host disease with features of scleroderma.
Charley MR; Deng JS
Immunol Ser; 1989; 46():625-40. PubMed ID: 2488872
[No Abstract] [Full Text] [Related]
17. Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis.
Avouac J; Elhai M; Tomcik M; Ruiz B; Friese M; Piedavent M; Colonna M; Bernhardt G; Kahan A; Chiocchia G; Distler JH; Allanore Y
Ann Rheum Dis; 2013 Jun; 72(6):1089-98. PubMed ID: 23161903
[TBL] [Abstract][Full Text] [Related]
18. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]